Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial

BACKGROUND: Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy. METHODS: We asses...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Matthews, Lynn T., Sibeko, Sengeziwe, Mansoor, Leila E., Yende-Zuma, Nonhlanhla, Bangsberg, David R., Karim, Quarraisha Abdool
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589407/
https://ncbi.nlm.nih.gov/pubmed/23472071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056400
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak